SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-19-001463
Filing Date
2019-05-14
Accepted
2019-05-14 11:54:02
Documents
192
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 20-F zk1922964.htm 20-F 5217078
2 EXHIBIT 12.1 exhibit_12-1.htm EX-12.1 8443
3 EXHIBIT 12.2 exhibit_12-2.htm EX-12.2 8422
4 EXHIBIT 13.1 exhibit_13-1.htm EX-13.1 5549
5 EXHIBIT 13.2 exhibit_13-2.htm EX-13.2 5551
6 EXHIBIT 15.1 exhibit_15-1.htm EX-15.1 9053
  Complete submission text file 0001178913-19-001463.txt   25520326

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT trib-20181231.xml EX-101.INS 7761146
8 XBRL TAXONOMY EXTENSION SCHEMA trib-20181231.xsd EX-101.SCH 179702
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE trib-20181231_cal.xml EX-101.CAL 176506
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE trib-20181231_def.xml EX-101.DEF 583640
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE trib-20181231_lab.xml EX-101.LAB 952371
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE trib-20181231_pre.xml EX-101.PRE 834611
Mailing Address 3 ROCK ROAD SANDYFORD INDUSTRIAL ESTATES DUBLIN IRELAND L2 18
Business Address IDA BUSINESS PARK, BRAY, CO WICKLOW IRELAND DUBLIN IRELAND L2 18 01135312955111
TRINITY BIOTECH PLC (Filer) CIK: 0000888721 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-22320 | Film No.: 19821384
SIC: 2835 In Vitro & In Vivo Diagnostic Substances